CompletedPhase 2NCT00351533

A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Washington
Principal Investigator
Renee D. Stapleton, MD, MSc
University of Vermont
Intervention
Fish oil (eicosapentaenoic acid and docosahexanoic acid)(drug)
Enrollment
90 enrolled
Eligibility
18 years · All sexes
Timeline
20062009

Study locations (5)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · American Thoracic Society · Acute Respiratory Distress Syndrome Foundation · American Society for Parenteral and Enteral Nutrition

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00351533 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials